{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:20:49Z","timestamp":1773303649585,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,11]]},"DOI":"10.7759\/cureus.105040","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:50:03Z","timestamp":1773237003000},"source":"Crossref","is-referenced-by-count":0,"title":["Divergent Mechanisms of Antidepressant Efficacy: A Unified Computational Comparison of Synaptogenesis, Stabilization, and Tonic Inhibition in a Model of Depression"],"prefix":"10.7759","author":[{"given":"Ngo","family":"Cheung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"World Mental Health Report: Transforming Mental Health For All","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. World Mental Health Report: Transforming Mental Health For All. World Health Organization, 2022."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush AJ","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, et al.. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006, 163:1905-17. 10.1176\/ajp.2006.163.11.1905","journal-title":"Am J Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi MH","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, et al.. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006, 163:28-40. 10.1176\/appi.ajp.163.1.28","journal-title":"Am J Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough JW","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang LC, et al.. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013, 170:1134-42. 10.1176\/appi.ajp.2013.13030392","journal-title":"Am J Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/2040622315579059","article-title":"Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review","volume":"6","author":"Iadarola ND","year":"2015","unstructured":"Iadarola ND, Niciu MJ, Richards EM, et al.. Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review. Ther Adv Chronic Dis. 2015, 6:97-114. 10.1177\/2040622315579059","journal-title":"Ther Adv Chronic Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13019","article-title":"Development of neuroactive steroids for the treatment of postpartum depression","volume":"34","author":"Gunduz-Bruce H","year":"2022","unstructured":"Gunduz-Bruce H, Takahashi K, Huang MY. Development of neuroactive steroids for the treatment of postpartum depression. J Neuroendocrinol. 2022, 34:e13019. 10.1111\/jne.13019","journal-title":"J Neuroendocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-023-06427-2","article-title":"Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy","volume":"240","author":"Reddy DS","year":"2023","unstructured":"Reddy DS, Mbilinyi RH, Estes E. Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy. Psychopharmacology (Berl). 2023, 240:1841-63. 10.1007\/s00213-023-06427-2","journal-title":"Psychopharmacology (Berl)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman RS","year":"2012","unstructured":"Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012, 338:68-72. 10.1126\/science.1222939","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02625-2","article-title":"Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder","volume":"29","author":"Page CE","year":"2024","unstructured":"Page CE, Epperson CN, Novick AM, Duffy KA, Thompson SM. Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder. Mol Psychiatry. 2024, 29:3802-13. 10.1038\/s41380-024-02625-2","journal-title":"Mol Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4238","article-title":"Computational psychiatry as a bridge from neuroscience to clinical applications","volume":"19","author":"Huys QJ","year":"2016","unstructured":"Huys QJ, Maia TV, Frank MJ. Computational psychiatry as a bridge from neuroscience to clinical applications. Nat Neurosci. 2016, 19:404-13. 10.1038\/nn.4238","journal-title":"Nat Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-310737","article-title":"Computational Psychiatry: towards a mathematically informed understanding of mental illness","volume":"87","author":"Adams RA","year":"2016","unstructured":"Adams RA, Huys QJ, Roiser JP. Computational Psychiatry: towards a mathematically informed understanding of mental illness. J Neurol Neurosurg Psychiatry. 2016, 87:53-63. 10.1136\/jnnp-2015-310737","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.18246390","article-title":"Simulating synaptic pruning and ketamine-like recovery in depression: insights from consolidation duration and iterative regimens on resilience and relapse","author":"Cheung N","year":"2026","unstructured":"Cheung N. Simulating synaptic pruning and ketamine-like recovery in depression: insights from consolidation duration and iterative regimens on resilience and relapse. Zenodo. 2026, 10.5281\/zenodo.18246390","journal-title":"Zenodo"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0615-x","article-title":"Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model","volume":"25","author":"Price RB","year":"2020","unstructured":"Price RB, Duman R. Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. Mol Psychiatry. 2020, 25:530-43. 10.1038\/s41380-019-0615-x","journal-title":"Mol Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.02.005","article-title":"Ketamine: a paradigm shift for depression research and treatment","volume":"101","author":"Krystal JH","year":"2019","unstructured":"Krystal JH, Abdallah CG, Sanacora G, Charney DS, Duman RS. Ketamine: a paradigm shift for depression research and treatment. Neuron. 2019, 101:774-8. 10.1016\/j.neuron.2019.02.005","journal-title":"Neuron"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0327(98)00221-3","article-title":"Mechanism of action of serotonin selective reuptake inhibitors: Serotonin receptors and pathways mediate therapeutic effects and side effects","volume":"51","author":"Stahl SM","year":"1998","unstructured":"Stahl SM. Mechanism of action of serotonin selective reuptake inhibitors: Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord. 1998, 51:215-35. 10.1016\/s0165-0327(98)00221-3","journal-title":"J Affect Disord"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02285-2","article-title":"The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective","volume":"13","author":"Boschloo L","year":"2023","unstructured":"Boschloo L, Hieronymus F, Lisinski A, Cuijpers P, Eriksson E. The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective. Transl Psychiatry. 2023, 13:19. 10.1038\/s41398-022-02285-2","journal-title":"Transl Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/473975-divergent-mechanisms-of-antidepressant-efficacy-a-unified-computational-comparison-of-synaptogenesis-stabilization-and-tonic-inhibition-in-a-model-of-depression","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:50:04Z","timestamp":1773237004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/473975-divergent-mechanisms-of-antidepressant-efficacy-a-unified-computational-comparison-of-synaptogenesis-stabilization-and-tonic-inhibition-in-a-model-of-depression"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.105040","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,11]]}}}